Multiple Myeloma
Featured Articles
(AACR) Oct 12, 2017 - Stand Up To Cancer (SU2C) has awarded 10 SU2C Catalyst® clinical trial projects in which researchers from more than 30 institutions collaborate across academic and corporate borders on clinical trials – with correlated translational research which will deepen our understanding of why treatments are effective –...
Read Article
(Endpoints News) Oct 12, 2017 - Karyopharm Therapeutics has inked a regional Asian deal for its late-stage cancer therapy selinexor and a follow-up compound it has in the pipeline.
Read Article
Latest Articles
October 11, 2017
October 05, 2017
October 04, 2017
September 29, 2017
September 27, 2017
September 25, 2017
September 18, 2017
September 18, 2017
View More
News Commentary
Editor Image
02 Apr, 2017 | by Winston Wong, PharmD
Ok. So maybe the there was a bit of overexcitement from NantKwest's product. ...
View Comment
Editor Image
16 Jun, 2017 | by Winston Wong, PharmD
This sounds like the same play innovator manufacturers are playing in the...
View Comment
View More
OBR Green
There are no Multiple Myeloma OBR Green articles.
OBR Blog
This year's ASH Annual Meeting will be chock-full of interesting, informative, and clinically useful presentations,... Read more
November 22, 2016